221 related articles for article (PubMed ID: 23408552)
1. Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.
Ahn KH; Scott CE; Abrol R; Goddard WA; Kendall DA
Proteins; 2013 Aug; 81(8):1304-17. PubMed ID: 23408552
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.
Scott CE; Abrol R; Ahn KH; Kendall DA; Goddard WA
Protein Sci; 2013 Jan; 22(1):101-13. PubMed ID: 23184890
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
Ahn KH; Mahmoud MM; Kendall DA
J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
[TBL] [Abstract][Full Text] [Related]
4. A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation.
D'Antona AM; Ahn KH; Wang L; Mierke DF; Lucas-Lenard J; Kendall DA
Brain Res; 2006 Sep; 1108(1):1-11. PubMed ID: 16879811
[TBL] [Abstract][Full Text] [Related]
5. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
Fay JF; Farrens DL
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
[TBL] [Abstract][Full Text] [Related]
6. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
Nebane NM; Kellie B; Song ZH
FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818
[TBL] [Abstract][Full Text] [Related]
7. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.
McAllister SD; Hurst DP; Barnett-Norris J; Lynch D; Reggio PH; Abood ME
J Biol Chem; 2004 Nov; 279(46):48024-37. PubMed ID: 15326174
[TBL] [Abstract][Full Text] [Related]
8. Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.
D'Antona AM; Ahn KH; Kendall DA
Biochemistry; 2006 May; 45(17):5606-17. PubMed ID: 16634642
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi.
Shim JY; Ahn KH; Kendall DA
J Biol Chem; 2013 Nov; 288(45):32449-32465. PubMed ID: 24092756
[TBL] [Abstract][Full Text] [Related]
10. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.
Marcu J; Shore DM; Kapur A; Trznadel M; Makriyannis A; Reggio PH; Abood ME
J Pharmacol Exp Ther; 2013 May; 345(2):189-97. PubMed ID: 23426954
[TBL] [Abstract][Full Text] [Related]
12. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT
Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.
Shim JY; Khurana L; Kendall DA
Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549
[TBL] [Abstract][Full Text] [Related]
14. C-terminal truncated cannabinoid receptor 1 coexpressed with G protein trimer in Sf9 cells exists in a precoupled state and shows constitutive activity.
Chillakuri CR; Reinhart C; Michel H
FEBS J; 2007 Dec; 274(23):6106-15. PubMed ID: 17986258
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation of the cannabinoid CB1 receptor.
Price MR; Baillie GL; Thomas A; Stevenson LA; Easson M; Goodwin R; McLean A; McIntosh L; Goodwin G; Walker G; Westwood P; Marrs J; Thomson F; Cowley P; Christopoulos A; Pertwee RG; Ross RA
Mol Pharmacol; 2005 Nov; 68(5):1484-95. PubMed ID: 16113085
[TBL] [Abstract][Full Text] [Related]
16. Understanding the role of the CB1 toggle switch in interaction networks using molecular dynamics simulation.
Ji S; Yang W; Yu W
Sci Rep; 2021 Nov; 11(1):22369. PubMed ID: 34785728
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into CB1 Receptor Biased Signaling.
Al-Zoubi R; Morales P; Reggio PH
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013934
[TBL] [Abstract][Full Text] [Related]
18. Impact of the DRY motif and the missing "ionic lock" on constitutive activity and G-protein coupling of the human histamine H4 receptor.
Schneider EH; Schnell D; Strasser A; Dove S; Seifert R
J Pharmacol Exp Ther; 2010 May; 333(2):382-92. PubMed ID: 20106995
[TBL] [Abstract][Full Text] [Related]
19. Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.
Nie J; Lewis DL
J Neurosci; 2001 Nov; 21(22):8758-64. PubMed ID: 11698587
[TBL] [Abstract][Full Text] [Related]
20. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
